Technical Analysis for RCEL - Avita Medical Limited

Grade Last Price % Change Price Change
grade D 27.3 -6.02% -1.75
RCEL closed down 6.02 percent on Friday, July 10, 2020, on 2.08 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical RCEL trend table...

Date Alert Name Type % Chg
MACD Bearish Centerline Cross Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
Oversold Stochastic Weakness 0.00%
180 Bearish Setup Bearish Swing Setup -6.02%
Calm After Storm Range Contraction -6.02%
Narrow Range Bar Range Contraction -6.02%
Multiple of Ten Bearish Other -6.02%
Outside Day Range Expansion -6.02%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Avita Medical Limited operates as a regenerative medicine company in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients 18 years and older. The company has a preclinical research collaboration with the University of Colorado School of Medicine to establish and explore development of a spray-on treatment for patients with epidermolysis bullosa. The company is based in Valencia, California.
Medicine Clinical Medicine Rare Diseases Healthcare Professionals Regenerative Medicine Platform Technology Burns Genodermatoses Injuries Wound Skin Chronic Wounds Epidermolysis Bullosa

Is RCEL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 153.55
52 Week Low 20.0
Average Volume 75,889
200-Day Moving Average 38.17
50-Day Moving Average 32.95
20-Day Moving Average 35.88
10-Day Moving Average 41.45
Average True Range 12.36
ADX 37.75
+DI 15.27
-DI 72.93
Chandelier Exit (Long, 3 ATRs ) 116.48
Chandelier Exit (Short, 3 ATRs ) 63.07
Upper Bollinger Band 89.54
Lower Bollinger Band -17.79
Percent B (%b) 0.42
BandWidth 299.16
MACD Line -0.06
MACD Signal Line 1.92
MACD Histogram -1.9839
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 29.46
Resistance 3 (R3) 29.44 28.71 29.10
Resistance 2 (R2) 28.71 28.16 28.72 28.98
Resistance 1 (R1) 28.00 27.82 27.64 28.02 28.86
Pivot Point 27.27 27.27 27.08 27.28 27.27
Support 1 (S1) 26.56 26.72 26.20 26.58 25.74
Support 2 (S2) 25.83 26.38 25.84 25.62
Support 3 (S3) 25.12 25.83 25.50
Support 4 (S4) 25.14